Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – What’s Next?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $21.35, but opened at $20.61. Daiichi Sankyo shares last traded at $21.39, with a volume of 45,788 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Trading Up 0.3%

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The stock’s 50 day moving average is $23.32 and its 200-day moving average is $23.89. The company has a market capitalization of $40.58 billion and a P/E ratio of 20.21.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.